Evecxia is developing treatments for severe depression and suicidal ideation which affect 7 million people in the U.S. alone
A first-in-class cell therapy platform that holds the potential to restore vision in the millions of people worldwide with retinal diseases
MAIA reports positive topline safety data from its Phase 2 clinical trial in advanced Non-Small Cell Lung Cancer
Belhaven’s needle-free delivery system solves every problem associated with EpiPens, including cost.
One of the most efficient and productive ways to mine precious metals is from the 53 megatons of e-Waste produced globally every year
Kineta has developed a new monoclonal antibody designed to reverse immunosuppression and stimulate T Cells.
Global Bioenergies has developed a process to synthesize Isobutene from plants which will save millions of tons of CO2.
Inmedix CloudHRV™ Platform provides actionable stress measurements to improve patient outcomes and reduce cost of care.
QSAM has refined an FDA-approved treatment creating a heat seeking missile that has the potential to cure metastatic bone cancer
Gain Therapeutics has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2021 FORCE Family Office